NASDAQ : RNXT
RenovoRx, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.49 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 67.24M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
RenovoRx, Inc. (RNXT) reported revenue of 1.98M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.98M | 1.12M | 43.00K | |||
| Cost of Revenue | 308.00K | 327.00K | ||||
| Gross Profit | 1.67M | 796.00K | 43.00K | |||
| Selling, General & Admin | 9.58M | 7.04M | 4.99M | 5.73M | 5.65M | 2.63M |
| Research & Development | 5.13M | 5.77M | 6.03M | 5.67M | 4.30M | 3.04M |
| Operating Expenses | 14.71M | 12.81M | 11.01M | 11.40M | 9.95M | 5.67M |
| Operating Income | -13.04M | -12.01M | -10.97M | -11.40M | -9.95M | -5.67M |
| Interest Expense | -834.00K | |||||
| Interest & Investment Income | 322.00K | 427.00K | 384.00K | 108.00K | 57.00K | |
| Other Non Operating Income (Expenses) | 935.00K | 915.00K | 1.77M | 1.06M | 4.00K | 119.00K |
| EBT Excluding Unusual Items | -11.78M | -10.67M | -8.81M | -10.23M | -9.89M | -6.39M |
| Other Unusual Items | -500.00K | -500.00K | 62.00K | |||
| Pretax Income | -12.29M | -11.17M | -8.81M | -10.23M | -9.89M | -6.32M |
| Net Income | -12.29M | -11.17M | -8.81M | -10.23M | -9.89M | -6.32M |
| Net Income to Common | -12.29M | -11.17M | -8.81M | -10.23M | -9.89M | -6.32M |
| Shares Outstanding (Basic) | 39.68M | 35.33M | 22.27M | 10.29M | 9.05M | 5.22M |
| Shares Outstanding (Diluted) | 39.68M | 35.33M | 22.27M | 10.29M | 9.05M | 5.22M |
| EPS (Basic) | -0.31 | -0.32 | -0.40 | -0.99 | -1.09 | -1.21 |
| EPS (Diluted) | -0.31 | -0.32 | -0.40 | -0.99 | -1.09 | -1.21 |
| Free Cash Flow | -11.94M | -10.97M | -9.14M | -10.26M | -8.81M | -5.93M |
| Free Cash Flow Per Share | -0.30 | -0.31 | -0.41 | -1.00 | -0.97 | -1.14 |
| Gross Margin | 84.41% | 70.88% | 100.00% | |||
| Operating Margin | -659.92% | -1,069.46% | -25,511.63% | |||
| Profit Margin | -621.71% | -994.48% | -20,497.67% | |||
| Free Cash Flow Margin | -604.10% | -977.29% | -21,248.84% | |||
| EBITDA | -13.03M | -12.01M | -11.39M | -9.94M | -5.66M | |
| D&A For EBITDA | 6.00K | 2.00K | 6.00K | 6.00K | 9.00K | |
| EBIT | -13.04M | -12.01M | -10.97M | -11.40M | -9.95M | -5.67M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.48M | 7.02M | 7.15M | 1.17M | 4.39M | 15.19M |
| Short-Term Investments | 2.05M | |||||
| Cash & Short-Term Investments | 9.48M | 7.02M | 7.15M | 1.17M | 6.44M | 15.19M |
| Receivables | 480.00K | 139.00K | 43.00K | |||
| Inventory | 383.00K | 189.00K | ||||
| Prepaid Expenses | 315.00K | 324.00K | 328.00K | 168.00K | 825.00K | 1.09M |
| Other Current Assets | 153.00K | 217.00K | 303.00K | 125.00K | ||
| Total Current Assets | 10.81M | 7.89M | 7.83M | 1.47M | 7.26M | 16.28M |
| Property, Plant & Equipment | 462.00K | 202.00K | 290.00K | 6.00K | ||
| Other Long-Term Assets | 200.00K | |||||
| Total Assets | 11.47M | 8.10M | 8.12M | 1.47M | 7.26M | 16.29M |
| Accounts Payable | 866.00K | 799.00K | 586.00K | 561.00K | 534.00K | 525.00K |
| Accrued Expenses | 887.00K | 1.06M | 1.26M | 614.00K | 568.00K | 413.00K |
| Current Portion of Leases | 131.00K | 105.00K | 66.00K | |||
| Total Current Liabilities | 1.88M | 1.96M | 1.91M | 1.18M | 1.10M | 938.00K |
| Long-Term Leases | 259.00K | 107.00K | 212.00K | |||
| Other Long-Term Liabilities | 350.00K | 604.00K | 1.52M | 3.29M | ||
| Total Liabilities | 2.49M | 2.67M | 3.64M | 4.47M | 1.10M | 938.00K |
| Common Stock | 5.00K | 4.00K | 2.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 76.79M | 66.81M | 54.70M | 38.40M | 37.32M | 36.63M |
| Retained Earnings | -67.82M | -61.39M | -50.22M | -41.41M | -31.17M | -21.28M |
| Comprehensive Income & Other | 17.00K | |||||
| Total Common Equity | 8.98M | 5.42M | 4.48M | -3.00M | 6.16M | 15.35M |
| Shareholders' Equity | 8.98M | 5.42M | 4.48M | -3.00M | 6.16M | 15.35M |
| Total Liabilities & Equity | 11.47M | 8.10M | 8.12M | 1.47M | 7.26M | 16.29M |
| Total Debt | 390.00K | 212.00K | 278.00K | |||
| Net Cash (Debt) | 9.09M | 6.81M | 6.88M | 1.17M | 6.44M | 15.19M |
| Net Cash Per Share | 0.23 | 0.19 | 0.31 | 0.11 | 0.71 | 2.91 |
| Filing Date Shares Outstanding | 45.13M | 45.05M | 36.55M | 16.87M | 9.10M | 9.03M |
| Total Common Shares Outstanding | 45.12M | 36.61M | 24.03M | 10.69M | 9.10M | 8.93M |
| Working Capital | 8.93M | 5.93M | 5.92M | 291.00K | 6.16M | 15.34M |
| Book Value Per Share | 0.20 | 0.15 | 0.19 | -0.28 | 0.68 | 1.72 |
| Tangible Book Value | 8.98M | 5.42M | 4.48M | -3.00M | 6.16M | 15.35M |
| Tangible Book Value Per Share | 0.20 | 0.15 | 0.19 | -0.28 | 0.68 | 1.72 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -12.29M | -11.17M | -8.81M | -10.23M | -9.89M | -6.32M |
| Depreciation & Amortization | 6.00K | 2.00K | 6.00K | 9.00K | ||
| Other Amortization | 697.00K | |||||
| Stock-Based Compensation | 1.52M | 1.27M | 1.17M | 1.08M | 644.00K | 147.00K |
| Other Operating Activities | -832.00K | -827.00K | -1.76M | -1.71M | -180.00K | |
| Change in Accounts Receivable | -117.00K | -96.00K | ||||
| Change in Inventory | -383.00K | -189.00K | ||||
| Change in Accounts Payable | 176.00K | 213.00K | 25.00K | 27.00K | 363.00K | |
| Change in Other Net Operating Assets | 46.00K | -175.00K | 255.00K | 578.00K | 428.00K | -628.00K |
| Operating Cash Flow | -11.87M | -10.97M | -9.12M | -10.26M | -8.81M | -5.92M |
| Capital Expenditures | -71.00K | -2.00K | -12.00K | -15.00K | ||
| Investment in Securities | 2.03M | -2.03M | ||||
| Investing Cash Flow | -71.00K | -2.00K | -12.00K | 2.03M | -2.03M | -15.00K |
| Short-Term Debt Issued | 1.98M | |||||
| Total Debt Issued | 1.98M | |||||
| Net Debt Issued (Repaid) | 1.98M | |||||
| Issuance of Common Stock | 10.00M | 12.14M | 17.35M | 5.01M | 42.00K | 17.35M |
| Other Financing Activities | -898.00K | -1.30M | -2.23M | |||
| Financing Cash Flow | 9.10M | 10.85M | 15.12M | 5.01M | 42.00K | 19.33M |
| Net Cash Flow | -2.83M | -130.00K | 5.98M | -3.22M | -10.80M | 13.40M |
| Free Cash Flow | -11.94M | -10.97M | -9.14M | -10.26M | -8.81M | -5.93M |
| Free Cash Flow Margin | -604.10% | -977.29% | -21,248.84% | |||
| Free Cash Flow Per Share | -0.30 | -0.31 | -0.41 | -1.00 | -0.97 | -1.14 |
| Levered Free Cash Flow | -6.65M | -6.42M | -5.41M | -5.44M | -5.14M | -4.59M |
| Unlevered Free Cash Flow | -6.65M | -6.42M | -5.41M | -5.44M | -5.14M | -4.77M |
| Cash Interest Paid | 15.00K | 16.00K | 21.00K | |||
| Cash Income Tax Paid | 1.00K | 2.00K | ||||
| Change in Working Capital | -278.00K | -247.00K | 280.00K | 605.00K | 428.00K | -265.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 60.02M | 30.79M | 30.96M | 24.49M | 21.38M | 43.12M |
| Enterprise Value | 50.93M | 20.98M | 21.40M | 21.26M | 13.27M | 25.39M |
| Last Close Price | 1.33 | 0.84 | 1.29 | 2.29 | 2.35 | 4.84 |
| PS Ratio | 30.38 | 27.42 | 720.04 | |||
| PB Ratio | 6.68 | 5.68 | 6.91 | -8.16 | 3.47 | 2.81 |
| P/TBV Ratio | 6.68 | 5.68 | 6.91 | 3.47 | 2.81 | |
| EV/Sales Ratio | 25.78 | 18.68 | 497.64 | |||
| Debt / Equity Ratio | 0.04 | 0.04 | 0.06 | |||
| Net Debt / Equity Ratio | -1.01 | -1.26 | -1.54 | 0.39 | -1.04 | -0.99 |
| Net Debt / EBITDA Ratio | 0.70 | 0.57 | 0.10 | 0.65 | 2.68 | |
| Net Debt / FCF Ratio | 0.76 | 0.62 | 0.75 | 0.11 | 0.73 | 2.56 |
| Asset Turnover | 0.16 | 0.14 | 0.01 | |||
| Quick Ratio | 5.29 | 3.65 | 3.77 | 1.00 | 5.84 | 16.20 |
| Current Ratio | 5.74 | 4.02 | 4.10 | 1.25 | 6.59 | 17.36 |
| Return on Equity (ROE) | -125.23% | -225.62% | -1,192.69% | -646.98% | -91.94% | -96.23% |
| Return on Assets (ROA) | -64.90% | -92.59% | -143.08% | -163.15% | -52.81% | -38.95% |
| Return on Capital Employed (ROCE) | -136.00% | -195.80% | -176.70% | -3,916.20% | -161.40% | -36.90% |
| Earnings Yield | -23.28% | -36.27% | -28.47% | -41.78% | -46.25% | -14.67% |
| FCF Yield | -19.89% | -35.64% | -29.51% | -41.89% | -41.21% | -13.76% |
| Buyback Yield / Dilution | -34.40% | -58.65% | -116.42% | -13.69% | -73.50% | -135.64% |